Clonidine in Children

Links shared publicly online about this topic

Pediatrics Article | Clonidine

mdlinx.com — “Oral bioavailability of clonidine in childrenView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on November 3, 2010 at 2:13 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Oral bioavailability of clonidine in children: Paediatric Anaesthesia http://bit.ly/a1QpXP #peds

2 years ago...

Shionogi Announces FDA Approval of Kapvay - The First and Only Therapy Approved for Use with Stimulant Medication for the Treatment of ADHD

drugs.com — “Kapvay (clonidine hydrochloride) is used to treat Attention Deficit Hyperactivity Disorder (ADHD). Includes Kapvay side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 4, 2010 at 11:57 pm By:

drugscom Drugs.com Health Site

FDA Approves Kapvay for the Treatment of ADHD - http://bit.ly/9mCUK6

2 years ago...

First ADHD Add-On Drug Approved | Psych Central News

psychcentral.com — “The U.S. Food and Drug Administration (FDA) has given the green light to the nonstimulant medication Kapvay (clonidine hydrochloride) as the first drug used toView full resource at psychcentral.com

  • View Related
  • Share

Most Recently Shared on October 7, 2010 at 2:36 pm By:

Shionogi Announces FDA Approval Of KAPVAY™ - The First And Only Therapy Approved For Use With Stimulant Medication For The Treatment Of ADHD

medicalnewstoday.com — “Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., announced the U.S. Food and Drug Administration approval of the non-stimulant medication KAPVAY™ (clonidine hydrochlorideView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 6, 2010 at 3:05 pm By:

mnt_adhd MNT ADHD & ADD News Health News

Shionogi Announces FDA Approval Of KAPVAY™ - The First And Only Therapy Approved For Use With Stimulant Medicati... http://mnt.to/3KPx

2 years ago...

Neurology Article | Attention Deficit Disorder with Hyperactivity

mdlinx.com — “Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHDView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 8, 2011 at 11:56 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With... http://bit.ly/me919S #neuro

12 months ago...

Kapvay approved for ADHD - MPR

empr.com — “The FDA has approved Kapvay (clonidine HCl extended-release tablets, from Shionogi) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6"17 years old.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on October 4, 2010 at 3:00 pm By:

eMPR MPR Medical Publisher

MPR News: Kapvay approved for ADHD: The FDA has approved Kapvay (clonidine HCl extended-release tablets, from Shio... http://bit.ly/9MiFxk

2 years ago...

Kapvay available for ADHD - ONA

oncologynurseadvisor.com — “Shionogi announced the availability of Kapvay (clonidine HCl extended-release tablets) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6--17 years old.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on January 10, 2011 at 4:17 pm By:

Drug Combo May Help Treat Kids With ADHD

m.webmd.com — “Combining an extended-release version of the blood pressure pill clonidine with a stimulant may benefit children with attention deficit hyperactivity disorder (ADHD) who are not getting adequate relief from stimulants alone, according to a new study.View full resource at m.webmd.com

  • View Related
  • Share

Most Recently Shared on May 12, 2011 at 6:43 pm By:

Health_CK Catherine K Health Advocate

Drug Combo May Help Treat Kids With ADHD: Combining an extended-release version of the blood pressure pill... http://bit.ly/mvZYav #adhd

1 year ago...

Phase 3 Study of Kapvay for ADHD - MPR

empr.com — “Shionogi Inc. announced thatdata from its Phase 3 study of Kapvay (clonidine hydrochloride) extended-release tablets combined with stimulant medications for the treatment of attention deficit hyperactivity disorder in children and adolescents 6-17 years of age.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 9, 2011 at 3:18 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 3 Study of Kapvay for ADHD: Shionogi Inc. announced that data from its Phase 3 study of Kapvay (... http://bit.ly/jBLDDp

1 year ago...

Phase 3 Study of Kapvay for ADHD - ONA

oncologynurseadvisor.com — “Shionogi Inc. announced thatdata from its Phase 3 study of Kapvay (clonidine hydrochloride) extended-release tablets combined with stimulant medications for the treatment of attention deficit hyperactivity disorder in children and adolescents 6-17 years of age.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on May 9, 2011 at 2:43 pm By:

Shionogi brings KAPVAY ADHD drug to the U.S market

news-medical.net — “Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced a true milestone as it marks the first commercial availability for the non-central nervous system stimulant medication KAPVAY™, an extended-release oral formulation of clonidine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on January 10, 2011 at 7:50 pm By:

Pregnancy_News News-Medical.Net Health News

Pregnancy News: Shionogi brings KAPVAY ADHD drug to the U.S market: Shionogi Inc., the U.S.-based group company ... http://bit.ly/hPgK0h

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • drugscom

    Drugs.com

    Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.

    View Profile

  • PeterBrownPsy

    Peter H Brown

    Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390